Have a feature idea you'd love to see implemented?
Let us know!
SPNT SiriusPoint Ltd
Price (delayed)
$15.37
Market cap
$2.49B
P/E Ratio
9.26
Dividend/share
N/A
EPS
$1.66
Enterprise value
$2.33B
SiriusPoint Ltd. is a top 20 global insurer and reinsurer providing solutions to clients and brokers in almost 150 countries. Bermuda-headquartered with offices around the world, we are listed on
Highlights
The equity has grown by 20% YoY
SiriusPoint's debt has decreased by 13% YoY
The net income has increased by 34% year-on-year but it has declined by 14% since the previous quarter
The EPS has grown by 33% YoY but it has contracted by 15% from the previous quarter
The P/E is 30% more than the last 4 quarters average of 7.1
SPNT's gross profit is down by 6% year-on-year and by 6% since the previous quarter
Key stats
What are the main financial stats of SPNT
Market
Valuations
Earnings
Shares outstanding
161.87M
Market cap
$2.49B
Enterprise value
$2.33B
Price to book (P/B)
0.97
Price to sales (P/S)
0.97
EV/EBIT
7.55
EV/EBITDA
7.27
EV/Sales
0.88
Revenue
$2.64B
EBIT
$309.2M
EBITDA
$321M
Free cash flow
$180.4M
Per share
Balance sheet
Liquidity
EPS
$1.66
Free cash flow per share
$1.09
Book value per share
$15.77
Revenue per share
$15.92
TBVPS
$75.69
Total assets
$12.68B
Total liabilities
$9.99B
Debt
$660.5M
Equity
$2.69B
Working capital
N/A
Debt to equity
0.25
Current ratio
N/A
Quick ratio
N/A
Net debt/EBITDA
-0.48
Margins
Efficiency
Dividend
EBITDA margin
12.2%
Gross margin
48.2%
Net margin
11.9%
Operating margin
12.7%
Return on assets
2.3%
Return on equity
11.4%
Return on invested capital
2.5%
Return on capital employed
N/A
Return on sales
11.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SPNT stock price
How has the SiriusPoint stock price performed over time
Intraday
0.46%
1 week
4.77%
1 month
13.43%
1 year
48.22%
YTD
32.5%
QTD
7.18%
Financial performance
How have SiriusPoint's revenue and profit performed over time
Revenue
$2.64B
Gross profit
$1.27B
Operating income
$335.7M
Net income
$314.7M
Gross margin
48.2%
Net margin
11.9%
SiriusPoint's net margin has increased by 40% YoY but it has decreased by 10% QoQ
The net income has increased by 34% year-on-year but it has declined by 14% since the previous quarter
The company's operating income fell by 18% YoY and by 17% QoQ
The operating margin has declined by 14% year-on-year and by 13% since the previous quarter
Growth
What is SiriusPoint's growth rate over time
Valuation
What is SiriusPoint stock price valuation
P/E
9.26
P/B
0.97
P/S
0.97
EV/EBIT
7.55
EV/EBITDA
7.27
EV/Sales
0.88
The EPS has grown by 33% YoY but it has contracted by 15% from the previous quarter
The P/E is 30% more than the last 4 quarters average of 7.1
The price to book (P/B) is 62% more than the 5-year quarterly average of 0.6 and 21% more than the last 4 quarters average of 0.8
The equity has grown by 20% YoY
The price to sales (P/S) is 39% higher than the 5-year quarterly average of 0.7 and 21% higher than the last 4 quarters average of 0.8
The revenue has contracted by 5% from the previous quarter and by 4.6% YoY
Efficiency
How efficient is SiriusPoint business performance
The return on assets is up by 28% year-on-year but it has declined by 15% since the previous quarter
The return on equity has declined by 19% since the previous quarter but it is up by 15% year-on-year
SPNT's ROIC is down by 17% since the previous quarter and by 11% year-on-year
The ROS has contracted by 15% from the previous quarter
Dividends
What is SPNT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SPNT.
Financial health
How did SiriusPoint financials performed over time
The total assets is 27% greater than the total liabilities
The total liabilities has declined by 3.3% year-on-year
SiriusPoint's debt is 75% lower than its equity
The debt to equity has declined by 26% year-on-year but it has grown by 4.2% since the previous quarter
The equity has grown by 20% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.